Business Context and Reporting Period
This Form 8-K filing by Lifeward Ltd. (formerly ReWalk Robotics Ltd.) covers the reporting period of November 2, 2024. The company is incorporated in Israel and maintains its principal executive offices in Marlborough, Massachusetts. The filing reports on corporate governance changes specifically regarding the Board of Directors.
Key Financial Metrics
This filing does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity metrics within this document.
Material Changes
The primary material change reported is the expansion of the Board of Directors from six to seven members. The Board appointed Robert J. Marshall Jr. as a new director, effective November 2, 2024. Key details of this change include:
- Role: Mr. Marshall serves as a Class III director until the 2026 annual meeting of shareholders.
- Committee Assignment: He was appointed as a member and chair of the Audit Committee.
- Independence: The Board determined Mr. Marshall is independent under Nasdaq listing rules.
- Background: Mr. Marshall previously served as CFO and Treasurer of Lantheus Holdings, Inc. and held senior finance roles at Zimmer Biomet Holdings, Inc.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking outlook, or discussion of operational risks. Regarding compensation, Mr. Marshall will receive standard compensation for non-employee directors as disclosed in the Company's Schedule 14A proxy statement filed on July 29, 2024. The filing explicitly states there are no related party transactions requiring disclosure and no family relationships between Mr. Marshall and existing directors or officers.
Investor Verification Checklist
- Verify the standard non-employee director compensation package referenced in the July 29, 2024, Schedule 14A proxy statement.
- Confirm the updated composition of the Audit Committee and the Board of Directors on the company's investor relations website.
- Review Mr. Marshall's prior disclosures at Lantheus Holdings and Zimmer Biomet for any potential conflicts of interest not detailed in this 8-K.
- Note that this filing is purely administrative and does not reflect changes in the company's financial condition or operational strategy.